Co-Diagnostics, Inc is a leading brand that specializes in molecular diagnostics, offering innovative solutions for the accurate and affordable detection of infectious diseases. With their cutting-edge PCR technology platform, they have revolutionized the field of molecular testing, enhancing the output of PCR tests and ensuring reliable results. Their range of diagnostic solutions includes Logix Smart™ assays for COVID-19, Zika, and tuberculosis, among others.

Additionally, Co-Diagnostics provides research solutions, including the Logix Smart ABC assay for research use only. The brand also offers Vector Control Solutions for agricultural applications. Co-Diagnostics' groundbreaking CoPrimers™ technology is a patented platform that significantly enhances the performance of molecular diagnostic tests.

By prioritizing accuracy and affordability, Co-Diagnostics is committed to improving patient outcomes, providing peace of mind, and potentially saving lives. Their vision is to make high-quality molecular diagnostics accessible to everyone. While the Co-Dx PCR Home testing platform is currently undergoing FDA review and not available for sale, it reflects the brand's dedication to empowering users with knowledge and the ability to take proactive measures.

For inquiries or assistance, Co-Diagnostics has a team ready to answer questions and provide support. Learn more about their transformative technology and contact them today